A study of docetaxel weekly or every three weeks in combination with carboplatin as first line chemotherapy in epithelial ovarian cancer: Hematological and non-hematological toxicity profiles

By        

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1140-1148

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel/carboplatin with or without sorafenib in the first‐line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 673-681

John Wiley & Sons Inc

Access to resources Recommend Favorite

First-Line Chemotherapy with Weekly Paclitaxel and Carboplatin for Advanced Ovarian Cancer: A Phase I Study

By Sehouli J.   Stengel D.   Elling D.   Ortmann O.   Blohmer J.   Riess H.   Lichtenegger W.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 321-326

Academic Press

Access to resources Recommend Favorite

Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer

By Covens A.   Carey M.   Bryson P.   Verma S.   Fung Kee Fung M.   Johnston M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 71-80

Elsevier

Access to resources Recommend Favorite

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer - a phase II study

By Pectasides D.   Visvikis A.   Kouloubinis A.   Glotsos J.   Bountouroglou N.   Karvounis N.   Ziras N.   Athanassiou A.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1194-1200

Elsevier

Access to resources Recommend Favorite